Hostname: page-component-5cf477f64f-qls9x Total loading time: 0 Render date: 2025-04-02T14:11:34.885Z Has data issue: false hasContentIssue false
  • English
  • Français

Sertindole in the treatment of tardive dyskinesia in a patient with genetically abnormal dopamine D3 receptors

Published online by Cambridge University Press:  24 June 2014

Emmanouil N. Rizos ,
Athanasios Douzenis ,
Ioannis Michopoulos ,
Nikolaos Siafakas ,
Eleni Katsantoni ,
Rossetos Gournellis  and
Lefteris Lykouras
Emmanouil N. Rizos*
Affiliation:
National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, Athens, Greece National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, Clinical and Molecular Psychogenetic Unit “ATTIKON” General Hospital, Athens, Greece
Athanasios Douzenis
Affiliation:
National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, Athens, Greece
Ioannis Michopoulos
Affiliation:
National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, Athens, Greece
Nikolaos Siafakas
Affiliation:
National and Kapodistrian University of Athens, Medical School, Laboratory of Clinical Microbiology, “ATTIKON” General Hospital, Athens, Greece
Eleni Katsantoni
Affiliation:
Biomedical Research Foundation, Academy of Athens, Hematology-Oncology Division, Athens, Greece
Rossetos Gournellis
Affiliation:
National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, Athens, Greece
Lefteris Lykouras
Affiliation:
National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, Athens, Greece
*
Emmanouil N. Rizos Lecturer in Psychiatry, National and Kapodistrian University of Athens, Medical School, Second Department of Psychiatry, “ATTIKON” General Hospital, 1 Rimini str., 12462 Athens, Greece. Tel: +302105832426; Fax: +302105326453; E-mail: erizos@med.uoa.gr
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comment & Critique
Information
Acta Neuropsychiatrica , Volume 22 , Issue 4 , August 2010 , pp. 209 - 210
Copyright
Copyright © 2010 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lerer, B, Segman, RH, Fangerau, Het al. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Glypolymorphism. Neuropsy-chopharmacology 2002;27:105–119. Google Scholar
American Psychiatric Association. APA Practice Guidelines for the treatment of psychiatric disorders-compendium. Washington DC: APA, 2004: 344. Google Scholar
Taylor, D, Paton, C, Kerwin, R.The South London and NHS Foundation Trust Oxleas NHS Foundation Trust: Prescribing Guidelines, 9th edn. Bodmin Cornwall UK: MPG Books, 2007: 99. Google Scholar
Llorca, PM, Cherau, I, Bayle, FJ, Lancon, C.Tardive dyskinesia and antipsychotics: a review. Eur Psychiatry 2002;17:129–138. Google Scholar
Steen, VM, Lovelie, R, MacEvan, T, McCreadie, RG.Dopamine D3 receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry 1997;2:139–145. Google Scholar
Spina, E, Zoccali, R.Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia. Exp Opin Drug Metab Toxicol 2008;4:629–638. Google Scholar
Hale, A, Azorin, JM, Kasper, Set al. Sertindole improves both the positive and negative symptoms of schizophrenia: results of a phase III trial. Int J Psychiatry Clin Pract 2000;4:55–62. Google Scholar
Perquin, L.Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects. Int Clin Psychopharmacol 2005;20:335–338. Google Scholar